Teprotumumab for Graves' orbitopathy and ototoxicity: moving problems from eyes to ears?

被引：25
作者：
Bartalena, L. [1 ]
Marino, M. [2 ]
Marcocci, C. [2 ]
Tanda, M. L. [1 ]
机构：
[1] Univ Insubria, Dept Med & Surg, Endocrinol, Via Guicciardini 9, I-21100 Varese, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
来源：
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 2022年 / 45卷 / 07期
关键词：
Teprotumumab; Graves' orbitopathy; Thyroid-eye disease; Hearing loss; Inflammatory bowel disease; Amyloid encephalopathy; HEARING-LOSS; DISEASE;
D O I：
10.1007/s40618-022-01791-w
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1455 / 1457
页数：3
相关论文
共 19 条
  • [1] New-Onset of Inflammatory Bowel Disease in a Patient Treated With Teprotumumab for Thyroid Associated Ophthalmopathy
    Ashraf, Davin C.
    Jankovic, Ivana
    El-Nachef, Najwa
    Winn, Bryan J.
    Kim, Grace E.
    Kersten, Robert C.
    [J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2021, 37 (05) : E160 - E164
  • [2] The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy
    Bartalena, L.
    Kahaly, G. J.
    Baldeschi, L.
    Dayan, C. M.
    Eckstein, A.
    Marcocci, C.
    Marino, M.
    Vaidya, B.
    Wiersinga, W. M.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (04) : G43 - G67
  • [3] Graves' Ophthalmopathy
    Bartalena, Luigi
    Tanda, Maria Laura
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) : 994 - 1001
  • [4] Teprotumumab and Hearing Loss: Case Series and Proposal for Audiologic Monitoring
    Belinsky, Irina
    Creighton, Francis X., Jr.
    Mahoney, Nicholas
    Petris, Carisa K.
    Callahan, Alison B.
    Campbell, Ashley A.
    Kazim, Michael
    Lee, H. B. Harold
    Yoon, Michael K.
    Glass, Lora R. Dagi
    [J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 38 (01) : 73 - 78
  • [5] Sensorineural Hearing Loss After Teprotumumab Therapy for Thyroid Eye Disease: A Case Report
    Ding, Andy S.
    Mahoney, Nicholas R.
    Campbell, Ashley A.
    Creighton, Francis X.
    [J]. OTOLOGY & NEUROTOLOGY, 2022, 43 (02) : E148 - E152
  • [6] Teprotumumab for the Treatment of Active Thyroid Eye Disease
    Douglas, R. S.
    Kahaly, G. J.
    Patel, A.
    Sile, S.
    Thompson, E. H. Z.
    Perdok, R.
    Fleming, J. C.
    Fowler, B. T.
    Marcocci, C.
    Marino, M.
    Antonelli, A.
    Dailey, R.
    Harris, G. J.
    Eckstein, A.
    Schiffman, J.
    Tang, R.
    Nelson, C.
    Salvi, M.
    Wester, S.
    Sherman, J. W.
    Vescio, T.
    Holt, R. J.
    Smith, T. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (04) : 341 - 352
  • [7] Teprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial Investigators
    Douglas, Raymond S.
    Wang, Yao
    Dailey, Roger A.
    Harris, Gerald J.
    Wester, Sara T.
    Schiffman, Jade S.
    Tang, Rosa A.
    Fowler, Brian
    Fleming, James
    Smith, Terry J.
    [J]. JOURNAL OF NEURO-OPHTHALMOLOGY, 2021, 41 (04) : 461 - 468
  • [8] Insulin-Like Growth Factor 1 on the Maintenance of Ribbon Synapses in Mouse Cochlear Explant Cultures
    Gao, Li
    Kita, Tomoko
    Katsuno, Tatsuya
    Yamamoto, Norio
    Omori, Koichi
    Nakagawa, Takayuki
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [9] Association of Hearing Loss With Hospitalization and Burden of Disease in Older Adults
    Genther, Dane J.
    Frick, Kevin D.
    Chen, David
    Betz, Joshua
    Lin, Frank R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (22): : 2322 - 2324
  • [10] Hoang TD, 2021, BMJ CASE REP, V14
12